Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modified Orbitozygomatic Approach for Resecting a Parasellar Tumor in a Single Institution.

Brain tumor research and treatment·2021
Same author

Variant facial artery anatomy revisited: Conventional angiography performed in 284 cases.

Medicine·2020
Same author

Waistband Mycosis Fungoides: A New Clinical Variant of Early-Stage Disease.

Skinmed·2019
Same author

Thyroid function tests in patients at the emergency department compared to a prior healthy setting.

PloS one·2018
Same author

Case of punctate palmoplantar keratoderma type I treated with combination of low-dose oral acitretin and topical salicylic acid and steroid.

The Journal of dermatology·2018
Same author

Procyanidins from <i>Vitis vinifera</i> seeds induce apoptotic and autophagic cell death via generation of reactive oxygen species in squamous cell carcinoma cells.

Oncology letters·2017
Same journal

The Relationship Between Melanoma Subtype and Organ-Specific Metastases: An Observational Study.

Annals of dermatology·2026
Same journal

The Upgrading Clinical Subtype Classification of Basal Cell Carcinoma is Useful to Correlate With Its Histologic Subtype and Local Invasiveness.

Annals of dermatology·2026
Same journal

Clinical Efficacy and Scalp Microbiome Changes Induced by AMPamide-Containing Shampoo in Patients With Seborrheic Dermatitis.

Annals of dermatology·2026
Same journal

Effects of Botulinum Toxin A on Rosacea-Like Inflammation in an LL-37-Induced Rosacea Mouse Model.

Annals of dermatology·2026
Same journal

Clinical Importance of Autoantibodies to SOX10 and Lamin A/C as Potential Biomarkers in Sera From Vitiligo Patients.

Annals of dermatology·2026
Same journal

A 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor, 11b-0048, Effectively Suppresses the Expression of 11β-HSD1 Activated in Cultured Keratinocytes and in Diabetic Murine Skin.

Annals of dermatology·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy
09:06

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy

Published on: March 29, 2024

Fluconazole induced fixed drug eruption.

Chi Yeon Kim1, Jin Gu Kim, Chee Won Oh

  • 1Department of Dermatology, School of Medicine, Gyeongsang National University & Gyeongsang Institute of Health Science, Jinju, Korea.

Annals of Dermatology
|October 27, 2011
PubMed
Summary
This summary is machine-generated.

A rare case of fluconazole-induced fixed drug eruption was observed in a 62-year-old female patient. Oral provocation confirmed the diagnosis, highlighting a unique presentation in dermatologic literature.

Keywords:
Drug eruptionFluconazole

More Related Videos

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Related Experiment Videos

Last Updated: May 28, 2026

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy
09:06

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy

Published on: March 29, 2024

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Area of Science:

  • Dermatology
  • Pharmacovigilance

Background:

  • Fixed drug eruption (FDE) is a specific type of adverse drug reaction.
  • Antifungal medications, such as fluconazole, can rarely cause FDE.

Observation:

  • A 62-year-old female presented with recurrent, itchy, erythematous maculopatches on her face, neck, arms, and trunk over six months.
  • The patient had been prescribed oral fluconazole for onychomycosis.

Findings:

  • Patch testing for fluconazole yielded negative results.
  • Oral provocation with fluconazole was positive, confirming fluconazole as the causative agent for the fixed drug eruption.
  • This represents the first reported case of fluconazole-induced FDE in Korean dermatologic literature.

Implications:

  • This case underscores the importance of considering FDE even with negative patch tests.
  • Oral provocation remains a crucial diagnostic tool for suspected FDE.
  • Clinicians should be aware of fluconazole as a potential cause of FDE, particularly in cases with recurrent lesions.